-

Posts Tagged ‘diabetes’

Podcast 95: What if hypertensive patients titrated their own drug dosages?

Joe Elia • July 9th, 2010

Categories: Audio, hypertension, Patient care, Uncategorized

(1 votes, average: 2.00 out of 5)

This week’s interview is with the editorialist commenting on an exciting Lancet paper. The writer, Dr. Gbenga Ogedegbe, says that the work, in which patients with uncontrolled hypertension titrated their own medications according to prespecified rules, could change how clinicians manage uncomplicated hypertension. From his base at New York University School of Medicine, Dr. [...]

Podcast 94: What does a new meta-analysis tell us about statins and primary prevention?

Joe Elia • July 1st, 2010

Categories: Audio, Cardiovascular risk, statins, Uncategorized

(9 votes, average: 4.44 out of 5)

A meta-analysis of 11 studies encompassing more than 60,000 subjects finds that statins don’t lower all-cause mortality in people without cardiovascular disease. One editorialist calls the study, just published in the Archives of Internal Medicine, “the cleanest and most complete meta-analysis of pharmacological lipid lowering for primary prevention.” One of the study’s principal authors, [...]

Podcast 92: Corticosteroids in COPD exacerbations — high-dose intravenous or low-dose oral?

Joe Elia • June 18th, 2010

Categories: Audio, chronic obstructive pulmonary disease, COPD, corticosteroids, Uncategorized

(8 votes, average: 3.50 out of 5)

A JAMA paper suggests that in all but the most severe exacerbations of COPD, it’s best to start off with low-dose oral corticosteroids rather than the higher-dose intravenous treatment that, contrary to guideline recommendations, almost everyone now gets. Our conversation this week is with the study’s first author, Dr. Peter Lindenauer. Visit the Journal [...]

Podcast 72: A conversation about two new drugs for multiple sclerosis.

Joe Elia • January 29th, 2010

Categories: Audio, cladribine, fingolimod, multiple sclerosis, Uncategorized

(2 votes, average: 5.00 out of 5)

We’ve got Dr. William Carroll this week — we tried last week, but the 13-hour time difference between Boston and Perth just stymied me. Dr. Carroll speaks about his NEJM editorial concerning two new drugs for multiple sclerosis. Both are oral therapies that work to keep lymphocytes at bay in this disease. Interview-story link: MS [...]

Podcast 63: A conversation about the adverse cardiometabolic effects of second-generation antipsychotic drugs in young patients with Christoph Correll

Joe Elia • November 2nd, 2009

Categories: antipsychotic drugs

(1 votes, average: 2.00 out of 5)

There are consequences of even short-term use of some drugs. Take the second-generation antipsychotics. A 3-month course can cause weight gain of almost 20 pounds in young people, according to a JAMA study. We interview Dr. Christoph Correll about the implications. To reach Clinical Conversations, you can call 1-617-440-4374 or email me at jelia@jwatch.org. This [...]

Podcast 59: A conversation about bacterial coinfection in 2009 H1N1 flu deaths with Dianna Blau of the CDC

Joe Elia • October 2nd, 2009

Categories: 2009 H1N1, Pneumococcal vaccine

(1 votes, average: 3.00 out of 5)

Early in the 2009 H1N1 pandemic, it was thought that bacterial coinfection was rare, but now that’s been shown to be untrue. Dr. Dianna Blau, one of the principal contributors to a study of coinfections in 77 fatal cases of 2009 H1N, is our guest. This week’s interview links: H1N1 Update: Bacterial Coinfection in H1N1-Related [...]